Skip to content
FDA drug shortage status

Is Caspofungin Acetate Injection in shortage?

Caspofungin Acetate Injection is listed by FDA as being discontinued by at least one maker (updated Jun 30, 2026).

Being discontinuedFDA status
3packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Caspofungin Acetate, Injection, 5 mg/1 mL (NDC 0781-3421-94)
    Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)Being discontinuedUpdated Jun 30, 2026Discontinued Jun 30, 2026

    Marketed by Sandoz, Inc.; Discontinuation of the manufacture of the drug

    Maker contact: Sandoz: 800-525-8747

  • Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 0781-3423-94)
    Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)Being discontinuedUpdated Jun 30, 2026Discontinued Jun 30, 2026

    Marketed by Sandoz, Inc.; Discontinuation of the manufacture of the drug

    Maker contact: Sandoz: 800-525-8747

  • Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10)
    Fresenius Kabi USA, LLCBeing discontinuedUpdated Jan 12, 2026Discontinued Jan 12, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 888-386-1300

Caspofungin Acetate Injection shortage questions

Is Caspofungin Acetate Injection in shortage?

Caspofungin Acetate Injection is listed by FDA as being discontinued by at least one maker (updated Jun 30, 2026).

What should I do if I can’t get Caspofungin Acetate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.